Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v7-EN
Language French English
Date Updated 2018-02-15 2018-02-15
Drug Identification Number 02385473 02385473
Brand name AZITHROMYCIN FOR INJECTION, USP AZITHROMYCIN FOR INJECTION, USP
Common or Proper name AZITHROMYCIN FOR INJECTION, USP AZITHROMYCIN FOR INJECTION, USP
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients AZITHROMYCIN AZITHROMYCIN
Strength(s) 500MG 500MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10VL 10VL
ATC code J01FA J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2017-07-12 2017-07-12
Remaining supply date 2017-07-31 2017-07-31
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Last Lot # 7602631 and Expires 31-Jul-17 Last Lot # 7602631 and Expires 31-Jul-17
Health Canada comments